U.S. Healthcare Large Cap High Growth Potential

DexCom

Market Cap: US$30.0b

A medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally.

Insulet

Market Cap: US$23.4b

Develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally.

Penumbra

Market Cap: US$10.3b

Designs, develops, manufactures, and markets medical devices in the United States and internationally.

Baxter International

Market Cap: US$12.3b

Through its subsidiaries, provides a portfolio of healthcare products in the United States.

Hims & Hers Health

Market Cap: US$11.5b

Operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally.

Doximity

Market Cap: US$13.5b

Operates as a digital platform for medical professionals in the United States.

Humana

Market Cap: US$32.8b

Provides medical and specialty insurance products in the United States.

Solventum

Market Cap: US$12.9b

A healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally.

Boston Scientific

Market Cap: US$146.7b

Develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide.

Stryker

Market Cap: US$144.0b

Operates as a medical technology company.